Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Medicine|August 11, 2017
Descriptive epidemiological study of vaginal cancer using data from the Osaka Japan population-based cancer registry: Long-term analysis from a clinical viewpointAsami Yagi, Yutaka Ueda, Mamoru Kakuda, et al.
International Journal of Clinical Oncology|July 25, 2022
Change of HPV vaccination rates in Japan: the effect of individual notifications implemented by local governmentsAsami Yagi, Yutaka Ueda, Satoshi Nakagawa, et al.
International Journal of Clinical Oncology|September 30, 2023
Intentions for catch-up HPV vaccination in Japan: an internet surveySatoshi Nakagawa, Asami Yagi, Yutaka Ueda, et al.
BMC Cancer|June 21, 2022
Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancerYoshikazu Nagase, Kosuke Hiramatsu, Masashi Funauchi, et al.
International Journal of Clinical Oncology|April 29, 2017
Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 casesYusuke Tanaka, Yutaka Ueda, Mamoru Kakuda, et al.
Obstetrics and Gynecology|June 9, 2016
Association of Low-Dose Aspirin and Survival of Women With Endometrial CancerKoji Matsuo, Sigita S Cahoon, Kosuke Yoshihara, et al.
Gynecologic Oncology|April 20, 2025
Temporal trends of sentinel lymph node biopsy without lymphadenectomy at cervical cancer surgeryEmmeline L Friedman, X Mona Guo, Katelyn B Furey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 12, 2025
Clinical and pathological characteristics and outcomes of small cell neuroendocrine carcinoma of the uterine cervixMariya Kobayashi, Satoshi Nakagawa, Tatsuo Masuda, et al.
Vaccines|September 23, 2022
Can Catch-Up Vaccinations Fill the Void Left by Suspension of the Governmental Recommendation of HPV Vaccine in Japan?Asami Yagi, Yutaka Ueda, Satoshi Nakagawa, et al.
Cancer Science|October 20, 2025
VRK1 Is a Novel Therapeutic Target for Small Cell Neuroendocrine Carcinoma of the CervixMariya Kobayashi, Satoshi Nakagawa, Yusuke Ishii, et al.
Pageof 6